Situation report: An AI system can now write a first-time prescription for a patient in the US. No doctor has to sign it before it goes out.
On Monday, healthcare startup Nolla Health announced that adults in Utah can scan their faces with its app. Its AI then rates how severe their acne is and writes a prescription on its own. The Verge AI reports that the service, called Nolla Derm, is starting as a pilot program, and Bloomberg broke the news first. Nolla says it’s the first company in the country to issue initial prescriptions this way. Others have only handled renewals.
That’s a real line to cross. Renewing a refill is paperwork. Choosing the first treatment is a diagnosis.
🎯 Key facts
- Who can use it: Utah residents who are 18 or older and have mild-to-moderate acne.
- Price: $4.99 a month.
- What it can prescribe: Eight different skin treatments, according to Bloomberg.
- Fallback: If the AI can’t “confidently select a treatment,” it sends the user to a physician.
- What Nolla says it’s for: “The pilot is designed to complement, not replace, physicians,” the company wrote in its press release. Nolla argues that taking routine, low-acuity cases off dermatologists’ plates frees them up for complex, high-risk patients.
🛡️ How the oversight works
This is the most interesting part. Physician oversight starts tight and gets looser in stages:
- Patients 1 to 100: Two physicians approve every AI-written prescription before it’s issued.
- Up to 500 patients: Physicians still review every prescription, but only after it’s been issued.
- After that: “Physicians review a sample of at least 10% of prescriptions every month, plus every case involving an escalation or side effect,” Nolla Health says.
In practice, Nolla is using its first few hundred patients to build a track record. If the AI matches physician judgment often enough, a human ends up checking about one prescription in ten. Self-driving car companies have handled safety drivers the same way: a human in the loop at first, then a human watching from a distance, then spot checks.
📍 Why Utah
Utah has made itself the country’s testing ground for AI in medicine. Earlier this year the state started letting AI systems renew certain medications, and several healthcare companies are already running AI prescription experiments there. Nolla is the first to go a step further.
Acne makes sense as a first target. It’s common, it’s easy to see in a photo, and treatment for mild-to-moderate cases follows well-known patterns. The downside of a wrong call is usually small compared with most medical decisions. If AI-written prescriptions are going to work anywhere, they should work here.
⚠️ Risks
Some open questions:
- Image quality: Phone cameras, lighting, and skin tone can all change what a vision model sees. How well does it work across different patients?
- Missed conditions: Rosacea and some other skin conditions can look like acne. A dermatologist might catch one where an app scan wouldn’t.
- Drift over time: Once review drops to a 10% sample, rare errors could take a while to show up.
- Liability: If an AI-written prescription causes harm, it isn’t clear who’s on the hook.
Nolla’s staged rollout deals with some of this. It doesn’t settle all of it.
🔭 What to watch
For people building health AI, this pilot is a template. It pairs a narrow use case and a cheap subscription with a clear way to hand off to a human and oversight that’s tied to measurable milestones. Expect competitors to copy the structure and push into other low-risk conditions.
For regulators in other states, Utah is running the experiment so they don’t have to. If Nolla’s numbers hold up through the first 500 patients, other states will feel more pressure to open their own doors. A safety problem would shut that down fast.
The key moment comes when Nolla moves from reviewing every prescription to checking a sample. More details are available in the original report from The Verge AI.